Verve Therapeutics, Inc.
Total Trades
52
Buys
2
Sells
32
Largest Trade
N/A
Insiders
11
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
32
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Kathiresan Sekar | CEO | EXERCISE | N/A | 33K | — | Apr 3, 2025 |
| Kathiresan Sekar | CEO | SELL | $15K–$50K | 10K | $4.15 | Apr 3, 2025 |
| Nickerson Joan | Chief Administrati… | EXERCISE | N/A | 9K | — | Apr 3, 2025 |
| Nickerson Joan | Chief Administrati… | SELL | $1K–$15K | 3K | $4.15 | Apr 3, 2025 |
| Ashe Andrew D. | See Remarks | SELL | $1K–$15K | 3K | $4.15 | Apr 3, 2025 |
| Ashe Andrew D. | See Remarks | EXERCISE | N/A | 9K | — | Apr 3, 2025 |
| Politi Jason | Chief Technical Op… | SELL | $1K–$15K | 3K | $4.15 | Apr 3, 2025 |
| Politi Jason | Chief Technical Op… | EXERCISE | N/A | 9K | — | Apr 3, 2025 |
| Dorval Allison | CFO | EXERCISE | N/A | 11K | — | Apr 3, 2025 |
| Dorval Allison | CFO | SELL | $1K–$15K | 3K | $4.15 | Apr 3, 2025 |
| Lister Troy | Chief Scientific O… | SELL | $1K–$15K | 2K | $4.15 | Apr 3, 2025 |
| Lister Troy | Chief Scientific O… | EXERCISE | N/A | 7K | — | Apr 3, 2025 |
| Dorval Allison | CFO | EXERCISE | N/A | 2K | — | Dec 3, 2024 |
| Dorval Allison | CFO | SELL | $1K–$15K | 555 | $5.64 | Dec 3, 2024 |
| Nickerson Joan | Chief Administrati… | SELL | $1K–$15K | 2K | $8.24 | Apr 3, 2024 |
| Nickerson Joan | Chief Administrati… | EXERCISE | N/A | 3K | — | Apr 3, 2024 |
| Dorval Allison | CFO | EXERCISE | N/A | 2K | — | Dec 1, 2023 |
| Dorval Allison | CFO | SELL | $1K–$15K | 554 | $11.45 | Dec 1, 2023 |
| Bellinger Andrew | CSO & CMO | SELL | $15K–$50K | 865 | $22.95 | Dec 2, 2022 |
| Dorval Allison | CFO | EXERCISE | N/A | 2K | — | Dec 1, 2022 |
| Dorval Allison | CFO | SELL | $1K–$15K | 554 | $22.10 | Dec 1, 2022 |
| Yeshwant Krishna | Director | SELL | $1M+ | 49K | $31.14 | Nov 8, 2022 |
| GV 2017 GP, L.L.C. | Insider | SELL | $1M+ | 97K | $31.14 | Nov 8, 2022 |
| Yeshwant Krishna | Director | SELL | $1M+ | 78K | $33.95 | Nov 4, 2022 |
| GV 2017 GP, L.L.C. | Insider | SELL | $1M+ | 156K | $33.95 | Nov 4, 2022 |
| Yeshwant Krishna | Director | SELL | $1M+ | 86K | $37.95 | Nov 3, 2022 |
| GV 2017 GP, L.L.C. | Insider | SELL | $1M+ | 171K | $37.95 | Nov 2, 2022 |
| Bellinger Andrew | CSO & CMO | SELL | $100K–$500K | 10K | $39.90 | Nov 1, 2022 |
| Bellinger Andrew | CSO & CMO | EXERCISE | $1K–$15K | 10K | $1.48 | Nov 1, 2022 |
| Kathiresan Sekar | CEO | SELL | $1M+ | 50K | $33.65 | Oct 5, 2022 |
| Kathiresan Sekar | CEO | EXERCISE | $50K–$100K | 50K | $1.39 | Oct 5, 2022 |
| Bellinger Andrew | CSO & CMO | SELL | $1M+ | 60K | $35.34 | Sep 27, 2022 |
| Bellinger Andrew | CSO & CMO | EXERCISE | $50K–$100K | 60K | $1.48 | Sep 27, 2022 |
| Kathiresan Sekar | CEO | EXERCISE | $50K–$100K | 50K | $1.39 | Aug 11, 2022 |
| Kathiresan Sekar | CEO | SELL | $1M+ | 50K | $29.90 | Aug 11, 2022 |
| Bellinger Andrew | CSO & CMO | EXERCISE | $15K–$50K | 20K | $1.39 | Jul 22, 2022 |
| Bellinger Andrew | CSO & CMO | SELL | $500K+ | 20K | $34.90 | Jul 22, 2022 |
| Kathiresan Sekar | CEO | SELL | $1M+ | 50K | $29.90 | Jul 21, 2022 |
| Kathiresan Sekar | CEO | EXERCISE | $50K–$100K | 50K | $1.39 | Jul 21, 2022 |
| Bellinger Andrew | CSO & CMO | SELL | $100K–$500K | 10K | $24.90 | Jul 15, 2022 |
| Bellinger Andrew | CSO & CMO | EXERCISE | $1K–$15K | 10K | $1.48 | Jul 15, 2022 |
| FMR LLC | 10% Owner | SELL | $1M+ | 163K | $20.78 | Jul 14, 2022 |
| FMR LLC | 10% Owner | SELL | $500K+ | 39K | $15.66 | Jul 6, 2022 |
| FMR LLC | 10% Owner | SELL | $500K+ | 53K | $15.45 | Jul 1, 2022 |
| ADELMAN BURT A | Director | BUY | $100K–$500K | 10K | $12.15 | May 13, 2022 |
| ADELMAN BURT A | Director | BUY | $50K–$100K | 4K | $21.38 | Mar 17, 2022 |
| FMR LLC | 10% Owner | SELL | $100K–$500K | 4K | $29.01 | Mar 11, 2022 |
| FMR LLC | 10% Owner | SELL | $100K–$500K | 13K | $29.46 | Feb 11, 2022 |
| FMR LLC | 10% Owner | SELL | $1M+ | 36K | $29.04 | Feb 3, 2022 |
| FMR LLC | 10% Owner | SELL | $1M+ | 159K | $31.12 | Jan 28, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 24K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Pentwater Capital Management LP
SC 13G · Aug 14, 2025
7.5%
6.7M shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G/A · Jul 28, 2025
0.0%
0 shares
SC 13G · Apr 29, 2025
4.9%
4.3M shares
SC 13G/A · Apr 17, 2025
7.0%
6.2M shares
SC 13G/A · Apr 17, 2025
7.0%
6.2M shares
SC 13G · Feb 5, 2025
3.8%
3.2M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Jan 31, 2025
3.4%
2.9M shares
SC 13G/A · Jan 11, 2025
0.0%
0 shares
Biotechnology Value Fund, L.P.
SC 13G · Nov 18, 2024
4.2%
3.5M shares
SC 13G/A · Nov 12, 2024
4.7%
4.0M shares
SC 13G/A · Nov 8, 2024
8.6%
7.3M shares
SC 13G/A · Nov 4, 2024
4.7%
4.0M shares
SC 13G/A · Oct 22, 2024
8.6%
7.3M shares
STATE STREET CORPORATION 04-2456637
SC 13G · Oct 16, 2024
5.0%
4.3M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Sep 9, 2024
5.4%
4.6M shares
SC 13G · Jun 27, 2024
5.1%
4.3M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
6.8%
5.5M shares
SC 13G · Jan 29, 2024
5.6%
4.4M shares
SC 13G/A · Jan 29, 2024
8.7%
7.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
4.8%
0 shares
SC 13G/A · Jan 16, 2024
3.7%
3.0M shares
SC 13G/A · Dec 11, 2023
7.6%
6.1M shares
SC 13G/A · Dec 11, 2023
4.8%
3.8M shares
SC 13G/A · Feb 14, 2023
8.1%
5.0M shares
SC 13G/A · Feb 14, 2023
3.7%
2.3M shares
SC 13G/A · Feb 10, 2023
9.9%
6.1M shares
SC 13G · Feb 10, 2023
7.1%
4.4M shares
SC 13G/A · Aug 10, 2022
11.0%
6.4M shares
SC 13G · Feb 14, 2022
13.1%
6.3M shares
SC 13G/A · Feb 14, 2022
6.5%
3.1M shares
SC 13G · Jan 24, 2022
5.1%
2.5M shares